Journal
MOLECULAR BIOLOGY REPORTS
Volume 39, Issue 7, Pages 7303-7309Publisher
SPRINGER
DOI: 10.1007/s11033-012-1560-9
Keywords
Cervical cancer; Molecular epidemiology; EpCAM; Polymorphism
Categories
Funding
- National Natural Scientific Foundation of China [81001278, 81072366, 81171895]
- Suzhou Science and Technology Agency [SYS201052]
- Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20101561]
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Jiangsu Provincial Natural Science Foundation of China [BK2011297]
- Jiangsu Province's Key Medical Department
- Beijing Nova Program [2009B03]
Ask authors/readers for more resources
The epithelial cell adhesion molecule (EpCAM) was originally identified as a tumor associated antigen, attributable to its high expression on rapidly proliferating tumors of epithelial origin. EpCAM plays vital roles in carcinogenesis, tumor progression and metastasis in most tumors. A non-synonymous polymorphism (rs1126497 C/T) was found in exon 3 of EpCAM, which cause a transition from 115 Met to 115 Thr. Another polymorphism (rs1421 A/G) in the 3'UTR causes loss of has-miR-1183 binding. We performed a multiple independent case-control analysis to assess the association between EpCAM genotypes and cervical cancer risk. Genotyping a total of 518 patients with cervical cancer and 723 control subjects in a Chinese population, we observed that the variant EpCAM genotypes (rs1126497 CT, and TT) were associated with substantially increased risk of cervical cancer. Compared with the rs1126497 CC genotype, CT genotype had a significantly increased risk of cervical cancer (Crude OR = 1.70; 95% CI = 1.33-2.20; adjusted OR = 1.72; 95% CI = 1.33-2.22), the TT carriers had a further increased risk of cervical cancer (Crude OR = 1.94; 95% CI = 1.01-3.72; adjusted OR = 1.96; 95%CI = 1.01-3.81), and there was a trend for an allele dose effect on risk of cervical cancer (P < 0.001). Moreover, the allele T increases the risk for invasive disease or metastatic disease, compared with C allele. However, there exists no significant difference in genotype frequencies of rs1421 A/G site between cases and controls (P = 0.798). These findings suggest that rs1126497 C/T polymorphism in EpCAM may be a genetic modifier for developing cervical cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available